Utilization trends of drugs in patients admitted with ischemic heart disease in a tertiary care teaching hospital
Keywords:Prescription auditing, Rational drug use, Drug utilization study, Coronary heart disease
Background: Coronary artery disease (CAD) takes the highest toll of lives across the world as well as India. Prompt diagnosis and effective treatment is lifesaving. Drug utilization studies scrutinize the appropriateness of treatment and provide favourable feedbacks to strengthen clinical practices. Several other studies have reported underuse of four evidence-based medicines namely aspirin, β-blockers, angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB), and statins in patients with CAD. Polypharmacy, injection overuse is some of the shortcomings. The objectives of this study was to describe treatment practices in terms of different disease spectrum and drug utilization (group-wise and individually) for inpatients with CAD using core prescription indicators by WHO.
Methods: A cross-sectional study of 4-month duration was undertaken for patients with CAD admitted to cardiology indoor of a tertiary care hospital. A total no of 143 prescriptions was screened and analyzed.
Results: Males (67.13%) were more in number than females (32.87%). Age group from (57-66) topped in frequency (61.05%) ahead of (67 to 76) group (38.46%). Average no of drugs per patient were 8.056±1.97 and 5.86±0.14 for cardiovascular drugs. Prescription in generics (45.49%), antibiotics (0.61%), fixed-dose combinations (FDCs) (0.52%) and injectables (28.47%) were noted. The most common categories of CAD were ST-segment elevated myocardial infarction (69.23%) followed by chronic stable angina (17.48%). Antiplatelets (100%), hypolipidemics (99.3%), antianginals (60.14%), β-blockers (37.06%) and ACE-I/ARBs (27.97%) were utilized. Drugs from the national list of essential medicines were 66.49%.
Conclusions: Among four evidence-based drugs, use of β-blockers and ACE-I/ARBs were inappropriately low. Polypharmacy and overuse of Injectable drugs are noted.
Cardiovascular diseases (CVDs). WHO Int 2019. Available at: https://www.who.int/en/news-room/ fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed on 24 September 2019.
How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators - EDM Research Series No. 007: Chapter 2: Core drug use indicators: Group 1: Prescribing indicators. Apps WHO Int 2019. Available at: https://apps.who.int/medicinedocs/en/d/ Js2289e/3.1.html. Accessed on 24 September 2019.
Sharma KK, Gupta R, Agrawal A. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vascular Health Risk Management. 2009;5:1007-14.
Ajay VS, Prabhakaran D. Coronary heart disease in Indians: implications of the inter heart study. Indian J Med Res. 2010;132(5):561-6.
Bandla A, Reddy K. A Study on Prescribing Pattern of Cardiovascular Drugs and Potential Drug-Drug Interactions in An Inpatient Cardiology Unit of a Cardiac - Care Hospital at Tirupathi. Eur J Pharma Med Res. 2016;3(8):294-305.
Christian R, Rana D, Malhotra S, Patel V. Evaluation of rationality in prescribing, adherence to treatment guidelines, and direct cost of treatment in intensive cardiac care unit: A prospective observational study. Indian J Crit Care Med. 2014;18(5):278-84.
Choudhary P, Agrawal JM, Malhotra SD, Patel VJ. Drug utilization pattern in acute coronary syndrome at tertiary care hospital: a prospective cross-sectional observational study. Int J Basic Clin Pharmacol. 2016;5:513-6.
Lakshmi SK, Gowda HN, Sadananda KS. A study of drug utilization trends in acute coronary syndrome in intensive cardiac care unit at a tertiary care hospital, Mysore. Int J Basic Clin Pharma. 2017;6(2):344.
Belhekar MN, Patel TC, Singh MK, Pandit PR, Bhave KA, Redkar NN. Evaluation of prescribing pattern of drugs use in patients of coronary artery disease at a tertiary care hospital. Int J Basic Clin Pharma. 2018;7(9):1792.
Kamath A, Shanbhag T, Shenoy S. A Descriptive Study of the Influence of Age and Gender on Drug Utilization in Acute Myocardial Infarction. J Clin Diagnos Res. 2010;(4):2041-6.
Kerkar SS, Bhandare PN. Study of utilization trends of drugs in patients admitted with cardiovascular diseases at a tertiary care hospital in Goa. Int J Sci Rep. 2017;3(12):311-7.
Isah A, Laing R, Quick J, Mabadeje A, Santoso B, Hogerzeil H, et al. The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators. West African J Pharma Drug Res. 2001;18(1).
Nagabushan H, Roopadevi HS, Prakash GM, Pankaja R. A prospective study of drug utilization pattern in cardiac intensive care unit at a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2015;4:579-83.
Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P, et al. Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India. Emergency Med Int. 2014;2014:1-5.
National List of Essential Medicines (NLEM) 2015 - India. Apps WHO Int 2017. Available at: http://apps. who.int/medicinedocs/en/m/abstract/Js23088en. Accessed on 16 October 2019.
Clinical Management Guidelines for Coronary Artery Disease for National Programme for Prevention and Control of Diabetes, Cardiovascular Disease and Stroke; 2010. Available at: http://www.searo.who. int/india/topics/cardiovascular_diseases/NCD_Resources_clinical_management_guidelines_for_cad.pdf?ua=1. Accessed on 16 October 2019.
Amsterdam E, Wenger N, Brindis R, Casey D, Ganiats T, Holmes D, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes. Circulation. 2014;130(25):344-426.